Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Dr Pepper Snapple, Keurig To Merge In A $18.7 Billion Deal By Zacks Investment Research - Jan 29, 2018

Shares of Dr Pepper Snapple Group Inc. (NYSE:DPS) soared more than 22% on Jan 29 after news came out that the beverage company will be acquired by coffee-maker Keurig Green Mountain, Inc.Terms of...

Zacks Investment Research
Rough Start To Busy Week By Zacks Investment Research - Jan 29, 2018

What a crazy week we have in store! Earnings season continues of course, but this time we’ll be getting the numbers from tech giants like Apple (NASDAQ:AAPL), Google (NASDAQ:GOOGL) and Amazon...

Zacks Investment Research
Can IPhone X Help Apple (AAPL) Post Earnings Beat In Q1? By Zacks Investment Research - Jan 29, 2018

Apple (NASDAQ:AAPL) is set to report first-quarter fiscal 2018 results on Feb 1. All eyes will be on the performance of the company’s latest flagship device — iPhone X.iPhone, since its...

Zacks Investment Research
Harley-Davidson (HOG) Q4 Earnings & Revenues Beat Estimates By Zacks Investment Research - Jan 29, 2018

Milwaukee, WI-based Harley-Davidson Inc. (NYSE:HOG) is a leading manufacturer and seller of custom, cruiser and touring motorcycles.EarningsIn the fourth-quarter, Harley-Davidson reported adjusted...

Zacks Investment Research
RedHill Biopharma (RDHL) In Focus: Stock Moves 10.2% Higher By Zacks Investment Research - Jan 29, 2018

RedHill Biopharma Ltd. (NASDAQ:RDHL) was a big mover last session, as the company saw its shares rise more than 10% on the day. The move came on solid volume too with far more shares changing hands...

Zacks Investment Research
Will Improved Top Line Aid CME Group's (CME) Q4 Earnings? By Zacks Investment Research - Jan 29, 2018

CME Group Inc. (NASDAQ:CME) is set to report fourth-quarter 2017 earnings on Feb 1 before the market opens. Notably, the company delivered a positive surprise in all the last four...

Zacks Investment Research
Masimo (MASI) Receives FDA Approval For SedLine, Shares Up By Zacks Investment Research - Jan 29, 2018

In a recent breakthrough, Masimo Corporation (NASDAQ:MASI) announced that its Next Generation SedLine brain function monitoring has received clearance from the FDA.The device will provide clinicians...

Zacks Investment Research
DowDuPont (DWDP) Q4 Earnings: Is A Beat In The Cards? By Zacks Investment Research - Jan 29, 2018

DowDuPont Inc. (NYSE:DWDP) is set to release fourth-quarter 2017 results before the opening bell on Feb 1.DowDuPont was formed through the $130-billion mega-merger of chemical giants, The Dow...

Zacks Investment Research
Why Earnings Season Could Be Great For Murphy Oil (MUR) By Zacks Investment Research - Jan 29, 2018

Investors are always looking for stocks that are poised to beat at earnings season and Murphy Oil Corporation (NYSE:MUR) may be one such company. The firm has earnings coming up pretty soon, and...

Zacks Investment Research
Cision (CISN) Jumps: Stock Rises 9.1% By Zacks Investment Research - Jan 29, 2018

Cision Ltd. (NYSE:CISN) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal...

Zacks Investment Research
Mattel's (MAT) Underperforming Brands To Hurt Q4 Revenues By Zacks Investment Research - Jan 29, 2018

Mattel, Inc. (NASDAQ:MAT) is scheduled to report fourth-quarter 2017 numbers on Feb 1, after market close.Last quarter, the company’s earnings missed the Zacks Consensus Estimate by 83.93%. In...

Zacks Investment Research
Abaxis (ABAX) At A 52-Week High: What's Driving The Stock? By Zacks Investment Research - Jan 29, 2018

Shares of Abaxis, Inc. (NASDAQ:ABAX) scaled a new 52-week high of $78.53 on Jan 29, closing lower at $76. The company has gained 62.7% in the last six months, way higher than the broader...

Continue with Apple
Continue with Google
or
Sign up with Email